Drug Type Small molecule drug |
Synonyms DQP 26, DQP26 |
Target |
Mechanism GRIN2C inhibitors(glutamate ionotropic receptor NMDA type subunit 2C inhibitors), GRIN2D inhibitors(glutamate ionotropic receptor NMDA type subunit 2D inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC28H21Cl2N3O4 |
InChIKeyPXQFOMCFQUXMBP-UHFFFAOYSA-N |
CAS Registry1449373-99-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Nervous System Diseases | Preclinical | US | 11 Aug 2023 |